Effectiveness of population-based service screening with mammography for women ages 40 to 49 years

Cancer

Volumn 117, Issue 4, 2011, Pages 714-722

  Hellquist, Barbro Numan ^a   Duffy, Stephen W ^b   Abdsaleh, Shahin ^c   Björneld, Lena ^d   Bordás, Pál ^e   Tabár, Lászlõ ^f   Viták, Bedrich ^g   Zackrisson, Sophia ^h   Nyström, Lennarth ⁱ   Jonsson, Håkan ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e SUNDERBY HOSPITAL   (Sweden)

^f FALUN HOSPITAL   (Sweden)

^g LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^h LUND UNIVERSITY   (Sweden)

ⁱ UMEÅ UNIVERSITY   (Sweden)

Author keywords

breast cancer; mammography; mortality; screening

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MAMMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; SWEDEN; AGE DISTRIBUTION; AGED; CANCER RISK; DISEASE DURATION; MAJOR CLINICAL STUDY; RISK REDUCTION; TIME TO TREATMENT; TREND STUDY;

EID: 79551718990     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25650     Document Type: Article

References (18)

1. Shapiro S, Strax P, Venet L., Periodic breast cancer screening in reducing mortality from breast cancer. JAMA. 1971; 215: 1777-1785.
2. Frisell J, Eklund G, Hellstrom L, Lidbrink E, Rutqvist LE, Somell A,. Randomized study of mammography screening-preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat. 1991; 18: 49-56.
3. Andersson I, Aspegren K, Janzon L, et al. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. BMJ. 1988; 297: 943-948.
4. Tabar L, Fagerberg CJ, Gad A, et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet. 1985; 1: 829-832.
5. Larsson LG, Andersson I, Bjurstam N, et al. Updated overview of the Swedish Randomized Trials on Breast Cancer Screening with Mammography: age group 40-49 at randomization. J Natl Cancer Inst Monogr. 1997;(22): 57-61.
6. Smart CR, Hendrick RE, Rutledge JH 3rd, Smith RA,. Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials. Cancer. 1995; 75: 1619-1626.
7. Andersson I, Janzon L., Reduced breast cancer mortality in women under age 50: updated results from the Malmo Mammographic Screening Program. J Natl Cancer Inst Monogr. 1997;(22): 63-67.
8. Bjurstam N, Björneld L, Duffy SW, et al. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Cancer. 1997; 80: 2091-2099.
9. Miller AB, To T, Baines CJ, Wall C,. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med. 2002; 137 (5 pt 1): 305-312.
10. Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L., Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet. 2006; 368: 2053-2060.
11. Jonsson H, Törnberg S, Nyström L, Lenner P., Service screening with mammography in Sweden-evaluation of effects of screening on breast cancer mortality in age group 40-49 years. Acta Oncol. 2000; 39: 617-623.
12. Jonsson H, Bordas P, Wallin H, Nyström L, Lenner P., Service screening with mammography in Northern Sweden: effects on breast cancer mortality-an update. J Med Screen. 2007; 14: 87-93. (Pubitemid 47067763)
13. Perry N, Broeders M, de Wolf C, Tornberg S, Holland R, von Karsa L,. European guidelines for quality assurance in breast cancer screening and diagnosis.Fourth edition-summary document. Ann Oncol. 2008; 19: 614-622.
14. US Preventive Services Task Force. Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2009; 151: 716-726. W-236.
15. R Development Core Team, R Foundation for Statistical Computing. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Development Core Team, R Foundation for Statistical Computing; 2009.
16. Cuzick J, Edwards R, Segnan N., Adjusting for non-compliance and contamination in randomized clinical trials. Stat Med. 1997; 16: 1017-1029.
17. Duffy SW, Day NE, Tabar L, Chen HH, Smith TC., Markov models of breast tumor progression: some age-specific results. J Natl Cancer Inst Monogr. 1997; 22: 93-97.
18. Törnberg S,. A Survey on Mammography Examinations Performed in Private Clinics During the Period 1992-93 [in Swedish]. Stockholm, Sweden: Socialstyrelsen; 1994.